Key facts
- This page summarizes Mark Simon's Form 4 filing for Cabaletta Bio, Inc. (CABA).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 03 Jun 2021, 16:31.
Mark Simon - 01 Jun 2021 Form 4 Insider Report for Cabaletta Bio, Inc. (CABA)
- Role
- Director
- Signature
- /s/ Anup Marda, Attorney-in-Fact
- Issuer symbol
- CABA
- Transactions as of
- 01 Jun 2021
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 03 Jun 2021, 16:31:00 UTC
- Next filing
- 03 Jun 2022
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Mark Simon filed Form 4 for Cabaletta Bio, Inc. (CABA) on 03 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
CABA
transaction
Derivative
Stock Option (Right to buy)
Award
- Transaction value
- $0
- Shares
- +22,000
- Change %
- Price
- $0.000000
- Shares after
- 22,000
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,000
- Exercise price
- $11.00
- Footnotes
- F1
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | This option shall vest in full upon the earlier of (1) June 1, 2022 or (2) the date of the next annual meeting of the Corporation's stockholders. |